Rheumatoid Arthritis Highlights From EULAR 2020

Review the latest RA management data with Capsule Summaries and expert-authored commentaries covering key studies from EULAR 2020.

Share

Program Content

Activities

  • RA Prevention and Treatment
    Rheumatoid Arthritis Prevention and Treatment: My Top Studies From EULAR 2020
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 16, 2020

    Expires: July 15, 2021

  • JAK Inhibitors
    EULAR 2020: New Data on JAK Inhibitors for Patients With RA
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 16, 2020

    Expires: July 15, 2021

  • RA Comorbidities
    Comorbidities in Rheumatoid Arthritis: My Top Studies From EULAR 2020
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 24, 2020

    Expires: August 23, 2021

  • After DMARD Failure
    Treating RA After DMARD Failure: Key Data From EULAR 2020
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 27, 2020

    Expires: August 26, 2021

Activities

Upadacitinib Infections
Infection Incidence With Upadacitinib in Patients With Rheumatoid Arthritis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 07, 2020

Expires: July 06, 2021

SRQ
SRQ: VTE Risk Increases Alongside Disease Activity Among Swedish Patients With Rheumatoid Arthritis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 13, 2020

Expires: August 12, 2021

Dutch Biologic Monitor
Dutch Biologic Monitor: Fatigue Among Biologic Recipients Across a Range of Immune-Mediated Inflammatory Diseases
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 13, 2020

Expires: August 12, 2021

JAK-POT
JAK-POT: Real-World Risk of Treatment Discontinuation Across 17 International Registers of Patients With Rheumatoid Arthritis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 01, 2020

Expires: June 30, 2021

VTE: Tofacitinib, Baricitinib
WHO VigiBase Analysis: Thromboembolic Safety of Tofacitinib, Baricitinib in Rheumatoid Arthritis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 01, 2020

Expires: June 30, 2021

Risk of HZ in RA Patients
RABBIT: Risk of Herpes Zoster Stratified by DMARD Type Among Patients With Rheumatoid Arthritis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 01, 2020

Expires: June 30, 2021

SELECT-CHOICE
SELECT-CHOICE: Upadacitinib vs Abatacept in Patients With Rheumatoid Arthritis With Inadequate Response or Intolerance to bDMARDs
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2020

Expires: August 16, 2021

FINCH 1 Wk 52
FINCH 1: 52-Wk Results of Filgotinib in Patients With Rheumatoid Arthritis With Inadequate Response to Methotrexate
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 13, 2020

Expires: July 12, 2021

Provided by

ProCE Banner

Supporters

AbbVie Inc.

Gilead Sciences, Inc.